Article Details

Organon and ObsEva Enter Global License Agreement to Develop and Commercialize Ebopiprant ...

Retrieved on: 2021-07-27 04:52:30

Tags for this article:

Click the tags to see associated articles and topics

Organon and ObsEva Enter Global License Agreement to Develop and Commercialize Ebopiprant .... View article details on hiswai:

Excerpt

JERSEY CITY, N.J. & GENEVA, Switzerland--(BUSINESS WIRE)--Jul 27, 2021--. Organon (NYSE: OGN), a global women's health company and ...

Article found on: www.cadillacnews.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up